8 Peripheral T-Cell Lymphoma Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Peripheral T-Cell Lymphoma Studies in New York

NCT07192471Recruiting

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

The purpose of this study is to determine the safety, tolerability, PK and pharmacodynamics of KK2223 in adult participants with relapsed or refractory peripheral T cell lymphoma (PTCL) or cutaneous T...

New York, NYPHASE172 participantsKyowa Kirin, Inc.

View Study Details

NCT04087629Recruiting

StrataCTX® as a Steroid Sparing Device

The purpose is to determine if StrataCTX® can be used as a steroid sparing agent for the treatment of cutaneous reactions related to, cutaneous T Cell lymphoma (CTCL) and chemotherapy/immunotherapy tr...

New York, NYNA70 participantsColumbia University

View Study Details

NCT05010005Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people wit...

New York, NYPHASE170 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04747236Recruiting

Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL

The purpose of this study is to find out whether the combination treatment of romidepsin and oral azacytidine is safe and effective in patients with Peripheral T-Cell Lymphoma (PTCL). This study will ...

New York, NYPHASE250 participantsUniversity of Virginia

View Study Details

NCT06534060Recruiting

MB-105 in Patients With CD5 Positive T-cell Lymphoma

This is a single arm, two-stage, Phase 2, open-label, multicenter study of MB-105 in patients with CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL). This study will apply a Simon tw...

New York, NYPHASE246 participantsMarch Biosciences Inc

View Study Details

NCT04234048Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....

New York, NYPHASE146 participantsSciTech Development, Inc.

View Study Details

NCT03829540Recruiting

CD4CAR for CD4+ Leukemia and Lymphoma

This study is designed as a single arm open label Phase I, 3x3, multicenter study of CD4-directed chimeric antigen receptor engineered T-cells (CD4CAR) in patients with relapsed or refractory T-cell l...

New York, NYPHASE120 participantsHuda Salman

View Study Details

NCT05296304Recruiting

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

The researchers are doing this study to test the safety of combining bexarotene with TSEB radiotherapy in people who have a common form of CTCL called mycosis fungoides (MF). Bexarotene is a form of ...

New York, NYPHASE120 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Peripheral T-Cell Lymphoma Clinical Trials in New York

Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.

There are currently 8 peripheral t-cell lymphoma clinical trials recruiting participants in New York, NY. These studies are seeking a combined 394 participants. Research is being sponsored by Kyowa Kirin, Inc., Columbia University, Memorial Sloan Kettering Cancer Center and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral T-Cell Lymphoma Clinical Trials in New York — FAQ

Are there peripheral t-cell lymphoma clinical trials in New York?

Yes, there are 8 peripheral t-cell lymphoma clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What peripheral t-cell lymphoma treatments are being tested?

The 8 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.

Data updated October 15, 2026 from ClinicalTrials.gov